CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,504 | 80,442 | ||
| 2024-02-13 | TZIANABOS ARTHUR Director | Option exercise | +31,739 | $2.19 | $70K | 31,739 |
| 2024-02-13 | TZIANABOS ARTHUR Director | Option exercise · Stock Option (Right to Buy) | −31,739 | 0 | ||
| 2024-02-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,000 | $4.80 | $48K | 6,981 |
| 2024-01-02 | Ticho Barry Chief Medical Officer | Sale 10b5-1 | −10,000 | $5.74 | $57K | 16,981 |
| 2023-12-01 | Tulipano Stephen J CFO | Returned to the company · Employee Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2023-12-01 | Tulipano Stephen J CFO | Returned to the company · Employee Stock Option (Right to Buy) | −65,600 | 0 | ||
| 2023-12-01 | Tulipano Stephen J CFO | Returned to the company · Employee Stock Option (Right to Buy) | −107,400 | 0 | ||
| 2023-12-01 | Tulipano Stephen J CFO | Grant or award · Restricted Stock Unit (RSU) | +60,773 | 60,773 | ||
| 2023-12-01 | Ticho Barry Chief Medical Officer | Returned to the company · Employee Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2023-12-01 | Ticho Barry Chief Medical Officer | Returned to the company · Employee Stock Option (Right to Buy) | −65,600 | 0 | ||
| 2023-12-01 | Ticho Barry Chief Medical Officer | Returned to the company · Employee Stock Option (Right to Buy) | −107,400 | 0 | ||
| 2023-12-01 | Ticho Barry Chief Medical Officer | Grant or award · Restricted Stock Unit (RSU) | +60,773 | 60,773 | ||
| 2023-12-01 | Nash Huw M. COO & CBO | Returned to the company · Employee Stock Option (Right to Buy) | −65,600 | 0 | ||
| 2023-12-01 | Nash Huw M. COO & CBO | Grant or award · Restricted Stock Unit (RSU) | +8,463 | 8,463 | ||
| 2023-12-01 | Kaye Edward M. MD CEO | Returned to the company · Employee Stock Option (Right to Buy) | −200,800 | 0 | ||
| 2023-12-01 | Kaye Edward M. MD CEO | Grant or award · Restricted Stock Unit (RSU) | +25,908 | 25,908 | ||
| 2023-12-01 | Allan Jonathan General Counsel & Corp Sec | Returned to the company · Employee Stock Option (Right to Buy) | −65,000 | 0 | ||
| 2023-12-01 | Allan Jonathan General Counsel & Corp Sec | Returned to the company · Employee Stock Option (Right to Buy) | −121,100 | 0 | ||
| 2023-12-01 | Allan Jonathan General Counsel & Corp Sec | Grant or award · Restricted Stock Unit (RSU) | +46,284 | 46,284 |
Page 19 of 24 · 461 trades